Document Detail


Methodological Issues and Evidence of Malfeasance in Research Purporting to Show Thimerosal in Vaccines Is Safe.
MedLine Citation:
PMID:  24995277     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
There are over 165 studies that have focused on Thimerosal, an organic-mercury (Hg) based compound, used as a preservative in many childhood vaccines, and found it to be harmful. Of these, 16 were conducted to specifically examine the effects of Thimerosal on human infants or children with reported outcomes of death; acrodynia; poisoning; allergic reaction; malformations; auto-immune reaction; Well's syndrome; developmental delay; and neurodevelopmental disorders, including tics, speech delay, language delay, attention deficit disorder, and autism. In contrast, the United States Centers for Disease Control and Prevention states that Thimerosal is safe and there is "no relationship between [T]himerosal[-]containing vaccines and autism rates in children." This is puzzling because, in a study conducted directly by CDC epidemiologists, a 7.6-fold increased risk of autism from exposure to Thimerosal during infancy was found. The CDC's current stance that Thimerosal is safe and that there is no relationship between Thimerosal and autism is based on six specific published epidemiological studies coauthored and sponsored by the CDC. The purpose of this review is to examine these six publications and analyze possible reasons why their published outcomes are so different from the results of investigations by multiple independent research groups over the past 75+ years.
Authors:
Brian Hooker; Janet Kern; David Geier; Boyd Haley; Lisa Sykes; Paul King; Mark Geier
Related Documents :
23424387 - Avian flu and the quest for immunity: not just chicken feed.
2960407 - Cytoskeleton of the unfertilized sea urchin egg.
24121847 - The uk pertussis epidemic: implications for immunisation.
24251777 - A systematic review and meta-analysis of phase i inactivated vaccines to reduce sheddin...
21170917 - Simultaneous confidence bounds for relative risks in multiple comparisons to control.
15088777 - Haemagglutination-inhibiting antibody to influenza virus.
Publication Detail:
Type:  REVIEW     Date:  2014-6-4
Journal Detail:
Title:  BioMed research international     Volume:  2014     ISSN:  2314-6141     ISO Abbreviation:  Biomed Res Int     Publication Date:  2014  
Date Detail:
Created Date:  2014-7-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101600173     Medline TA:  Biomed Res Int     Country:  -    
Other Details:
Languages:  ENG     Pagination:  247218     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The positive effects of one-hour intravenous administration of bortezomib on peripheral neuropathy i...
Next Document:  Endotracheal Intubation Using the Macintosh Laryngoscope or KingVision Video Laryngoscope during Uni...